NEU 2.37% $19.39 neuren pharmaceuticals limited

ANAVEX MEETS ENDPOINTS PHASE2 RETT, page-115

  1. 15,796 Posts.
    lightbulb Created with Sketch. 4074
    Wouldn't be surprised if potential bidders have approached the company already (they did hire the advisor), but I'm guessing they have been sent right back out the door to reflect on how petty their offers were. Management know what this is worth, and I'm hoping as money flows back into bio/healthcare stocks the bidders will be a bit more realistic with their offers
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.